Christopher Jorgensen
Directeur/Membre du Conseil chez Vapogenix, Inc.
Profil
Christopher Jorgensen is currently the Director at Vapogenix, Inc. and the Managing Director at Pamoja Capital SA. He has an undergraduate degree from the Woodrow Wilson School of Public & International Affairs.
Postes actifs de Christopher Jorgensen
| Sociétés | Poste | Début |
|---|---|---|
Vapogenix, Inc.
 Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Directeur/Membre du Conseil | - |
Pamoja Capital SA
 Pamoja Capital SA Investment ManagersFinance Pamoja Capital SA operates as a private investment firm. It specializes in long-term, socially-responsible, global investments across a number of industry sectors, including education, life sciences, information technology, real estate and media and communications. The firm's investments span all stages of corporate growth, including seed and growth capital. It seeks capital appreciation through long-term investments and emphasis on investing in businesses with sustainable cash flow. The company was founded by John H. McCall MacBain in 2006 and is headquartered in Geneva, Switzerland. | Corporate Officer/Principal | - |
Formation de Christopher Jorgensen
| Woodrow Wilson School of Public & International Affairs | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Vapogenix, Inc.
Vapogenix, Inc. Medical/Nursing ServicesHealth Services Vapogenix, Inc. operates as a clinical stage company which develops a new class of non-narcotic analgesics for localized pain. Its products are formulated volatile anesthetics; currently unformulated volatile anesthetics are used only as general anesthetics, by inhalation. The company was founded by Allen W. Burton, Phillip C. Phan and Danguole Spakevicius Altman in November 2007 and is headquartered in Houston, TX. | Health Services |
Pamoja Capital SA
Pamoja Capital SA Investment ManagersFinance Pamoja Capital SA operates as a private investment firm. It specializes in long-term, socially-responsible, global investments across a number of industry sectors, including education, life sciences, information technology, real estate and media and communications. The firm's investments span all stages of corporate growth, including seed and growth capital. It seeks capital appreciation through long-term investments and emphasis on investing in businesses with sustainable cash flow. The company was founded by John H. McCall MacBain in 2006 and is headquartered in Geneva, Switzerland. | Finance |
